Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alexander O. Schuth currently holds 242,346 shares of Denali Therapeutics Inc. (DNLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alexander O. Schuth has been a net seller of DNLI stock. They have purchased $0 and sold $17.4M worth of shares.
Alexander O. Schuth's most recent insider trade was on Aug 12, 2025, when they sold 2,937 shares at $13.58 per share.
Alexander O. Schuth serves as Executive at Denali Therapeutics Inc. (DNLI). They have executed 146 insider transactions totaling $17.4M over their tenure at the company.
Alexander O. Schuth holds the position of Executive at Denali Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Alexander O. Schuth has shown a selling trading pattern, with $0 in total purchases and $17.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alexander O. Schuth was on Feb 14, 2024, when they sold $355.5K worth of DNLI shares. This transaction involved 20,128 shares at $17.66 per share.
Alexander O. Schuth currently owns 242,346 shares of Denali Therapeutics Inc. (DNLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alexander O. Schuth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alexander O. Schuth has 146 Form 4 filings on record as an insider at Denali Therapeutics Inc..
Set alerts for Alexander O. Schuth and 40,000+ other insiders.